Diabetes mellitus - Strategic Insights Report (Page 2)

Diabetes therapy

GLP-1 Agonists Show Promise in Addressing Cardiovascular-Kidney-Metabolic Syndrome

According to a recent study published in Current Atherosclerosis Reports, glucagon-like peptide-1 receptor (GLP-1R) agonists have emerged as a multifaceted therapeutic option for addressing cardiovascular-kidney-metabolic (CKM) syndrome, microvascular dysfunction, and metabolic-associated steatohepatitis (MASH). These medications, originally developed for glycemic control in diabetes mellitus (DM), are now being explored for their

Bevacizumab

Economic Burden of Diabetic Macular Edema: Research Reveals Significant Costs and Utilization

Diabetic macular edema (DME), a leading cause of blindness, requires costly treatment with anti-vascular endothelial growth factor (VEGF) agents. However, a recent retrospective cohort study has estimated the long-term patient-centered economic burden of DME, revealing significant costs and utilization compared to those with diabetes mellitus (DM) without DME. The study

Diabetes mellitus

Diabetes and Thyroid Illnesses: A Growing Concern for Endocrine Conditions

Diabetes and thyroid illnesses are increasingly common endocrine conditions that often coexist in patients, leading to complex health issues. A recent study from the Saraswathi Institute of Medical Sciences has shed light on the significant relationship between these two conditions. Researchers found that patients with diabetes mellitus type 2 (T2DM)

Drugs

Breakthrough Research from Kyoto University: Insights into Cancer, Hair Loss, and Diabetes

Recent research from Kyoto University has shed light on innovative studies related to cancer, hair loss, and diabetes. In Study 1, researchers discuss the early stages of human T-cell leukemia virus type 1 infection in human lymphocytes using the human PBMC-NOG mouse model. The study reveals that the human PBMC-NOG

Drugs

Recent Studies at Harvard University Reveal Insights into Disease Mechanisms and Potential Therapies

Harvard University researchers have made significant contributions to the understanding of various diseases, shedding light on potential therapeutic approaches. A recent investigation discovered distinct structural and functional properties of the ATPase sites in an asymmetric ABC transporter, which has implications for understanding the transport of peptides into the endoplasmic reticulum.

Drugs

Recent Research from University of Texas, U.S., Reveals Insights into Molecular Imaging, DNA Ligase Activity, and Uric Acid Nephrolithiasis

Research from the University of Texas, U.S., has been shedding light on various aspects of molecular imaging, DNA ligase activity, and uric acid nephrolithiasis. The studies have shown promising results in the fields of cancer research, embryonic development, and diabetes management. Key Takeaways: * Recent research from the University of

Drugs

University of Bristol Researchers Publish New Study Data on Health Trends and Antioxidants

University of Bristol researchers in England have published new study data on health trends and antioxidants, finding potential links between childhood body mass index (BMI), adult insulin-like growth factor (IGF) levels, and chronic disease risk. Additionally, a second study suggests that highly active antiretroviral therapy (HAART) has improved virological response

Universities and colleges

Advances in Diabetes Research: New Findings from the University of Texas

Researchers at the University of Texas have made significant progress in understanding various aspects of diabetes, a chronic disease that affects millions worldwide. Recent studies have shed new light on the mechanisms underlying diabetic retinopathy, microvascular dysfunction, and weight gain in type 1 diabetes mellitus. Key Takeaways: * Diabetic retinopathy may

Drugs

CytRx Corporation Awarded $222,000 SBIR Grant to Develop Novel Inhibitors for Type 2 Diabetes and Obesity Treatment

CytRx Corporation, a biopharmaceutical company, has been awarded a Small Business Innovative Research (SBIR) grant of approximately $222,000 to develop novel inhibitors for the treatment of type 2 diabetes and obesity. The grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, part of the

Drugs

Advances in Diabetes Research: New Insights from Switzerland, France, and Denmark

Recent studies from Switzerland, France, and Denmark have shed light on new approaches to managing diabetes. A study from Switzerland found that adding acarbose to existing treatments for type 2 diabetes improved life expectancy and quality-adjusted life expectancy, while a study from France discovered a potential biomarker for assessing compliance

Universities and colleges

Diabetes Research Highlights Recent Breakthroughs in Understanding and Managing Diabetes

Researchers at the University of Florida have published three groundbreaking studies in the past year that shed new light on diabetes, its effects on the body, and potential methods for managing the disease. The studies, published in various medical journals, highlight the importance of insulin therapy, family functioning, and adherence

Drugs

Advances in Diabetes Research: New Findings from Japan, Taiwan, and the United States

Advances in diabetes research have been reported in three new studies from Japan, Taiwan, and the United States, providing insights into more effective treatments for type 1 diabetes mellitus and autonomic neuropathy. Researchers in Japan analyzed clinical data from 18,470 diabetic patients and found that intensive conventional insulin treatment

See all